ESTABLISHED
JUNE 1978
HEAD QUARTER
SEOUL, KOREA
EMPLOYEES
ABOUT 620
| CEO & President | Wonbum Lee |
|---|---|
| Sales Revenue(2022) | 194,258Million KRW |
| Stock Exchange Index | KOSPI |
| Head Office | Seoul, Korea |
| KGMP Plant | Anseong, Korea |
| R&D center | Suwon, Korea / Seoul, Korea |
| Main Therapeutic Areas | Central Nervous System (80%) Cardiovascular (6%) Gastrointestinal (3%) |
| Main Products | Quetiapine/Alprazolam/Agomelatine/Donepezil |
